Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase II Trial of MOnaliZumab in Combination With durvAlumab (MEDI4736) for tReatmenT of Small Cell Lung Cancer (MOZART)

This study has 2 cohorts: MOZART-ES cohort (for extensive-stage SCLC) and MOZART-LS cohort (for limited-stage SCLC). MOZART-ES cohort: Study treatment will co…

Small Cell Lung CancerSCLCExtensive Stage Small Cell Lung Cancer+1 more

Hirva MamdaniNCT05903092